ADVAX

Drug Profile

ADVAX

Alternative Names: HIV DNA vaccine - ADARC/IAVI

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Aaron Diamond AIDS Research Center; International AIDS Vaccine Initiative
  • Developer Aaron Diamond AIDS Research Center; Ichor Medical Systems; International AIDS Vaccine Initiative
  • Class Adjuvants; AIDS vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported HIV infections

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for phase-I development in HIV-infections(New delivery system, Prevention) in USA (IM)
  • 04 Nov 2017 No recent reports of development identified for phase-I development in HIV-infections(Prevention) in USA (IM)
  • 01 Dec 2009 Interim immunogenicity and adverse events data from a phase I trial in Healthy volunteers released by Ichor Medical Systems
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top